Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Large prostates link to more hair loss.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Using finasteride with TIP extends time off period for prostate cancer patients.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.